Robotically-assisted Minimally-invasive Direct Coronary Artery Bypass With Stenting, Randomized Against Coronary Artery Bypass Graft Surgery: a Pilot Trial

Cardiology Research UBC0 sites80 target enrollmentMay 1, 2024

ConditionsCoronary Artery Disease Multivessel Coronary Artery Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Coronary Artery Disease
Sponsor: Cardiology Research UBC
Enrollment: 80
Primary Endpoint: Post-operative Length of Stay
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The study objective is to compare standard CABG to a hybrid revascularization strategy (RA-MIDCAB + PCI) in patients who have multi-vessel CAD and an indication for surgery, but who have a slightly higher risk of post-operative complications.

Registry

clinicaltrials.gov

Start Date

May 1, 2024

End Date

December 1, 2028

Last Updated

2 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Cardiology Research UBC

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Multi-vessel CAD with an indication for revascularization,
•Presence of at least 1 risk factor for increased risk of post-operative death or major complication,
•Any patient Age \> 80, OR
•Any patient with eGFR (Glomerular Filtration Rate) \< 50, OR
•Any patient with LVEF \< 40%, OR
•Any patient deemed to be "frail" by consulting surgeon. OR
•Patients \> 75 years of age with at least one of the following:
•Ejection fraction \< 50%
•History of prior CVA (Cerebral Vascular Accident)
•Coronary artery anatomy appropriate for a robotically-assisted MIDCAB or regular CABG, vessels other than the left anterior descending with lesions amenable to either CABG or PCI.